Wenjun Cui1, Jing Zhang1, Kai Ai2, Yurong Zheng1, Yuping Bai1, Tiejun Gan1, Rui Wang1, Tingli Yang1, Pengfei Wang1, Jie Zou1, Haoyuan Li1, and Yuan Ding1
1Department of Magnetic Resonance,Lanzhou University Second Hospital, Lan Zhou, China, 2Philips Healthcare, Xi'an, China
Synopsis
Advanced radiological modalities such as
Amide Proton Transfer weighted imaging (APTw) may be useful in probing
biological tissue properties of pituitary adenomas. The objective of the
present study was to examine APTw derived APT value to noninvasively and
quantitatively measuring pituitary adenomas. Moreover, the
correlation analysis was performed between ATP value and hormone secretion to
validate the efficiency of ATP value in differentiate hormone secretion related
pituitary adenomas.
Introduction
It
is very important to differentiate different types of pituitary macroadenomas
because they frequently lead to the presence of chiasmatic syndrome. The classification of pituitary tumors is based on the staining
properties of the cell cytoplasm viewed by light microscopy and
immunocytochemistry revealing the secretory pattern of the adenoma1. Due to hormonal levels, pituitary macroadenomas can be classified as hyper-secreting,
non-secreting, hypo-secreting subtypes. Noninvasive
radiological biomarkers that can predict pituitary adenoma hormone secretion is
useful for predicting the extent of hormonal secretion, and identifying cases
in which transcranial surgery may be appropriate. Amide proton transfer
weighted (APTw) imaging is a novel molecular MRI technique to detect endogenous
mobile proteins and peptides through chemical exchange saturation transfer noninvasively.
In this preliminary study, we aimed to quantitative evaluating whether APT
value can be used as a reliable index to differentiate different types of pituitary
adenomas. Correlation analysis was further performed between APT value and hormone
secretion.Methods
Thirty-four
preoperative patients with pituitary adenomas were recruited. Patients were
scanned using a 3.0 T MR scanner (Ingenia CX, Philips Healthcare, the
Netherlands) with a 32-channel head coil. Then all patients were divided into
three groups: 18 subjects with hyper-secreting type (9 males; mean age ± standard
deviation: 44.55±12.93 years), 9 subjects with non-secreting type (7 males; 48.14±15.34
years), 7 subjects with hypo-secreting type (4 males; 61.25±6.99
years). All participants hormone profile were assessed by biochemical detection.
Imaging of the sellar region included the following sequences: coronal pre-contrast
two-dimensional (2D) T2-weighted turbo spin-echo (TSE) imaging (repetition time
[TR] /echo time [TE] = 3000/90 ms, matrix = 276 × 235, FOV = 170 × 180 mm2, slice thickness/gap
= 2.5/0.25 mm). Coronal APT imaging using 3D TSE-DIXON sequence (TR/TE = 6515/8.8ms,
matrix = 100×100, FOV = 180×180 mm2, flip angle=90°, slice thickness/gap
= 4/0 mm). APT value was obtained through Philips Intellispace Portal.
Two board-certified radiologists (both > 5 years’ experience) localized the
pituitary on coronal pre-contrast 2D T2-weighted images and APTw images.
they manually measured the maximum tumor
diameter of the pituitary macroadenoma on the coronal pre-contrast 2D T2-weighted
TSE images using a distance measurement function of a PACS workstation. Regions
of interest (ROIs) were drawn over the tumor on the
coronal slice of maximum lesion on the APT image conservatively to avoid tumor
boundaries and minimize partial volume effects. Areas with increased signal
distortion were excluded from ROI measures to reduce the role of air-tissue
interface artifacts. Equivalent ROIs were placed in the gray matter of
the left and right temporal lobes on the slice with the greatest tumor
cross-sectional area to accommodate for any B0 field inhomogeneity. Internal
consistency was measured by the Cronbach's alpha coefficient (α) and the
stability of the questionnaire was evaluated by estimating interclass
correlation coefficient (ICC). The association
between the APT value and the maximum tumor diameter was evaluated by using
simple linear regression analysis.Results
For
both radiologists, the agreement between the MRI-based localization and the
intraoperative findings increased after referring to the APT value and the
maximum tumor diameter of the pituitary macroadenoma (Table 1). The APT value of hyper-secreting type pituitary macroadenoma
was significantly higher than the hypo-secreting ones
(P = 0.001) (Table 2). The APT value between hyper-secreting type and non-secreting
type, non-secreting type and hypo-secreting type pituitary macroadenoma showed no
statistically significant, respectively (P = 0.196, P = 0.182). The maximum
tumor diameter had no significant linear correlation on
the APT value of tumor (R Square=0.006, unstandardized coefficients B=-0.085,
P=0.662, P>0.05) (Fig.1). The APT
value of the gray matter of the left and right temporal lobes on the slice with
the greatest tumor cross-sectional area lower than pituitary macroadenoma in three
groups, respectively. Figure 2 showed three typical patients with different subtype pituitary macroadenoma.Discussion
In our study, we determined that APT
imaging is able to predict the hormone secretion of pituitary macroadenoma. As
a result of the normal pituitary gland itself produces hormones and have high proteins
and peptides, The circulating hormone’s negative
feedback of Hypothalamic–Pituitary–Gonadal (HPG) axis can stimulate pituitary hyperplasia
or atrophy. Hyper-secreting type and hypo-secreting type pituitary macroadenoma
may tend to be the non-secreting type shape. The APT value between hyper-secreting
and non-secreting type, non-secreting and hypo-secreting type pituitary
macroadenoma shows no significant statistically differences, respectively. However,
Hyper-secreting pituitary macroadenomas are highly cellular secretory function
and have a higher cellular content of proteins and peptides than the
hypo-secreting pituitary macroadenoma. The APT value between hyper-secreting
type and hypo-secreting pituitary macroadenoma shows significantly statistical
difference. It also revealed by MRI-guided proteomics and in vivo MR
spectroscopy,2,3 and it has been assumed that amide proteins of
endogenous mobile proteins and peptides in the cytoplasm are the major source
of the APT signals4. Linear relationship does not exist between the
APT value of pituitary macroadenoma and the tumors size. It maybe further
indicates that the APT value is related to hormone secretion of tumor cells in
pathology.Conclusion
This study demonstrated the APT imaging can
be used to differentiate hormon-related pituitary adenoma. The APT value may
provide early imaging biomarkers for the early evaluation in pituitary adenoma diagnosis
and treatment.Acknowledgements
No acknowledgement found.References
1.Chanson P, Salenave S. Diagnosis and
treatment of pituitary adenomas. Minerva Endocrinol. 2004;29(4):241-275.
2. Hobbs, S. K. et al. Magnetic resonance
image-guided proteomics of human glioblastoma multiforme. J Magn Reson Imaging
18,530–536, https://doi.org/10.1002/jmri.10395 (2003).
3. Howe, F. A. et al. Metabolic profiles
of human brain tumors using quantitative in vivo H-1 magnetic resonance
spectroscopy. Magnet Reson Med 49, 223–232, https://doi.org/10.1002/mrm.10367
(2003).
4. Zhou, J., Lal, B., Wilson, D. A.,
Laterra, J. & van Zijl, P. C. Amide proton transfer (APT) contrast for
imaging of brain tumors. Magn Reson Med 50, 1120–1126,
https://doi.org/10.1002/mrm.10651 (2003).